185 related articles for article (PubMed ID: 9349470)
1. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants.
Chen YL; Ts'ai PW; Yang CC; Wang CT
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2497-501. PubMed ID: 9349470
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
3. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
Chiu HC; Yao SY; Wang CT
J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of wild-type HIV-1 virus production by a matrix deficient Gag mutant.
Lee PP; Linial ML
Virology; 1995 Apr; 208(2):808-11. PubMed ID: 7747455
[TBL] [Abstract][Full Text] [Related]
5. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
6. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
Park J; Morrow CD
J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561
[TBL] [Abstract][Full Text] [Related]
7. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
Lee PP; Linial ML
J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
[TBL] [Abstract][Full Text] [Related]
8. A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol.
Chien AI; Liao WH; Yang DM; Wang CT
Virology; 2006 Apr; 348(1):84-95. PubMed ID: 16442581
[TBL] [Abstract][Full Text] [Related]
9. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
Park J; Morrow CD
Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
[TBL] [Abstract][Full Text] [Related]
11. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
[TBL] [Abstract][Full Text] [Related]
12. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
Sova P; Volsky DJ; Wang L; Chao W
J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Liu H; Wu X; Xiao H; Conway JA; Kappes JC
J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
15. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
16. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
[TBL] [Abstract][Full Text] [Related]
17. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
Chazal N; Carrière C; Gay B; Boulanger P
J Virol; 1994 Jan; 68(1):111-22. PubMed ID: 8254720
[TBL] [Abstract][Full Text] [Related]
19. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.
Huang M; Martin MA
J Virol; 1997 Jun; 71(6):4472-8. PubMed ID: 9151838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]